Clinical Trials Sponsored by ViroMed Co., Ltd.

Total 10192 results

UnicoCell Biomed CO. LTD

Recruiting

Efficacy and Safety of ELIXCYTE Intra-articular Injection in Subject With Knee Osteoarthritis

Knee Osteoarthritis

Taiwan
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Trial of HBM9378 in Healthy Chinese Subjects

Asthma

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study

Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Thyroid Ophthalmopathy

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

Solid Tumor
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab

Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye

Dry Eye

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors

Solid Tumors
MiCo BioMed Co., Ltd.
Syntactx

Completed

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

SARS-CoV2 Infection

United States
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers

Healthy Chinese Volunteers

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients (MG)

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye

Dry Eye

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP

Primary Immune Thrombocytopenic Purpura

China
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study of HBM9161 in NMOSD Patients

NMO Spectrum Disorder

China
S&T Biomed Co., Ltd.

Completed

Verification of Saliva MMP-1 as a Diagnostic Marker of Oral Cavity Cancer

Oral Squamous Cell Carcinoma

Taiwan
Beijing Viroad Biotechnology Co., Ltd.

Unknown

The Detection of Circulating Tumor Cells (CTCs) in Breast Cancer With a Novel in Vivo Device

Circulating Tumor Cells.Breast

China
Shanghai Belief-Delivery BioMed Co., Ltd

Active, not recruiting

Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug

Hemophilia B

China
RenJi Hospital
Suzhou SinoMed Biomaterials Co., Ltd

Active, not recruiting

Exploratory Study on Safety of PEEK Knee Prosthesis

Osteoarthritis of the Knee | Rheumatoid Arthritis of Knee

China
RenJi Hospital
Beijing Viroad Biotechnology Co., Ltd.

Completed

CTC in Predicting Neoadjuvant Chemotherapy Among LABC Patients: a Single-center, Prospective, Exploratory Clinical Trial (CTCNeoBC)

Locally Advanced Breast Cancer | Circulating Tumor Cell

China
UnicoCell Biomed CO. LTD
Protech Pharmaservices Corporation (PPC)

Completed

Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease

Moderate to Severe Chronic Kidney Disease

Taiwan
UnicoCell Biomed CO. LTD
A2 Healthcare Taiwan Corporation

Completed

Adipose-derived Stem Cells (ADSCs) for Knee Osteoarthritis

Knee Osteoarthritis

Taiwan
Prima BioMed Ltd

Completed

Ovarian Cancer Vaccine for Patients in Remission

Epithelial Ovarian Cancer

United States, Australia
Prima BioMed Ltd

Withdrawn

Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas

Pancreatic Carcinoma Stage I | Pancreatic Carcinoma Stage II
Remedor Biomed Ltd

Completed

Topical Erythropoietin Hydrogel Formulation for Diabetic Foot Ulcers (Remede d'Or)

Diabetic Foot Ulcer

Israel
Prima BioMed Ltd

Completed

Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study (CAN-003X)

Epithelial Ovarian Cancer

United States, Australia
Prima BioMed Ltd

Terminated

Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment (CANVAS)

Epithelial Ovarian Cancer

United States, Australia
suhaichuan
Shanghai Biomed-union Biotechnology Co., Ltd.

Recruiting

Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)

Chemotherapy | Advanced Non-small Cell Lung Cancer

China
Shanghai Belief-Delivery BioMed Co., Ltd
Shanghai MYGT Biopharmaceutical LLC

Recruiting

Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs

Hemophilia A

China
suhaichuan
Shanghai Biomed-union Biotechnology Co., Ltd.

Unknown

A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors

Neoplasms | Advanced Solid Tumor
Triomed AB
Iqvia Pty Ltd

Enrolling by invitation

Carry Life@ UF System Clinical Study

End Stage Renal Disease

Sweden, United Kingdom
Sizhen Wang
Shanghai Biomed-union Biotechnology Co., Ltd.

Recruiting

The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer

Advanced Pancreatic Cancer

China
Beijing StarMab Biomed Technology Ltd

Recruiting

Clinical Study of SM3321 With Solid Tumors

Locally Advanced or Metastatic Solid Tumors

China
Huons Co., Ltd.
Humedix Co., Ltd.

Unknown

To Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds

Nasolabial FOLD

Korea, Republic of
InxMed (Shanghai) Co., Ltd.
InventisBio Co., Ltd

Recruiting

a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors

Solid Tumor

China
IlDong Pharmaceutical Co Ltd
YUNOVIA CO.,LTD.

Recruiting

Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects

Healthy Adult Subjects

Korea, Republic of
NanoCarrier Co., Ltd.
Orient Europharma Co., Ltd.

Recruiting

Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen

SCCHN

Croatia, Czechia, Hungary, Poland, Russian Federation, Serbia, Taiwan, Ukraine
CHABiotech CO., Ltd
Seoul CRO Co., Ltd.

Completed

Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain

Chronic Low-back Pain | Disc Degeneration

Korea, Republic of
Hyundai Bioland Co., Ltd.
Medipost Co Ltd.

Completed

Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus

Chondral or Osteochondral Lesion of Talus

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.
CliPS Co., Ltd

Completed

Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

Korea, Republic of
PegBio Co., Ltd.
Tigermed Consulting Co., Ltd

Completed

Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects

Type 2 Diabetes Mellitus

China
InventisBio Co., Ltd
InxMed (Shanghai) Co., Ltd.

Recruiting

Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors

Solid Tumor

China
Orient Europharma Co., Ltd.
NanoCarrier Co., Ltd.

Terminated

Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer

Head and Neck Neoplasms

Taiwan
Orient Europharma Co., Ltd.
NanoCarrier Co., Ltd.

Completed

Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer

Pancreatic Neoplasms

Taiwan, Japan, Hong Kong, Singapore, Philippines, Malaysia, Korea, Republic of
NanoCarrier Co., Ltd.
Orient Europharma Co., Ltd.

Completed

NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia

Locally Advanced and Metastatic Pancreatic Cancer

Taiwan, Singapore
Walvax Biotechnology Co., Ltd.
Abogen Biosciences Co. Ltd.; Yuxi Walvax Biotechnology Co., Ltd.

Recruiting

A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above

COVID-19 | SARS-CoV-2

Indonesia, Mexico
Gannex Pharma Co., Ltd.
Ascletis Pharmaceuticals Co., Ltd.

Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States
Oneness Biotech Co., Ltd.
Microbio Shanghai Co., Ltd.

Recruiting

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

Allergic Asthma

Taiwan
S.Biomedics Co., Ltd.
Yonsei University; Linical Co., Ltd.

Recruiting

Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI (SB-SCI-001)

Spinal Cord Injury, Acute | Spinal Cord Injury at C5-C7 Level With Complete Lesion | Spinal Cord Injury at C4 Level With Complete Lesion

Korea, Republic of

Clinical Trials Sponsored by ViroMed Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations